These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8297214)

  • 21. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
    Friedman J; Ault K; Powchik P
    Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
    [No Abstract]   [Full Text] [Related]  

  • 22. Placebo-controlled trial of glycine added to clozapine in schizophrenia.
    Evins AE; Fitzgerald SM; Wine L; Rosselli R; Goff DC
    Am J Psychiatry; 2000 May; 157(5):826-8. PubMed ID: 10784481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmentation of clozapine with ziprasidone in refractory schizophrenia: a double-blind, placebo-controlled study.
    Muscatello MR; Pandolfo G; Micò U; Lamberti Castronuovo E; Abenavoli E; Scimeca G; Spina E; Zoccali R; Bruno A
    J Clin Psychopharmacol; 2014 Feb; 34(1):129-33. PubMed ID: 24145221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
    Volavka J; Nolan KA; Kline L; Czobor P; Citrome L; Sheitman B; Lindenmayer JP; McEvoy J; Lieberman JA
    Schizophr Res; 2005 Jul; 76(1):127-9. PubMed ID: 15927808
    [No Abstract]   [Full Text] [Related]  

  • 25. Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
    Chouinard G; Annable L; Ross-Chouinard A
    Am J Psychiatry; 1982 Mar; 139(3):312-8. PubMed ID: 6120655
    [No Abstract]   [Full Text] [Related]  

  • 26. Do anticonvulsants hinder clozapine treatment?
    Wilson WH
    Biol Psychiatry; 1995 Jan; 37(2):132-3. PubMed ID: 7718678
    [No Abstract]   [Full Text] [Related]  

  • 27. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
    Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
    Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study.
    Sacchetti E; Galluzzo A; Valsecchi P; Romeo F; Gorini B; Warrington L;
    Schizophr Res; 2009 May; 110(1-3):80-9. PubMed ID: 19269791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison.
    Shopsin B; Klein H; Aaronsom M; Collora M
    Arch Gen Psychiatry; 1979 Jun; 36(6):657-64. PubMed ID: 375865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dysphoric syndrome in schizophrenia and its implications for relapse.
    Hirsch SR; Jolley AG
    Br J Psychiatry Suppl; 1989 Jul; (5):46-50. PubMed ID: 2690890
    [No Abstract]   [Full Text] [Related]  

  • 31. Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia.
    Kane JM; Rifkin A; Quitkin F; Nayak D; Ramos-Lorenzi J
    Arch Gen Psychiatry; 1982 Jan; 39(1):70-3. PubMed ID: 6275811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia.
    Potkin SG; Bera R; Gulasekaram B; Costa J; Hayes S; Jin Y; Richmond G; Carreon D; Sitanggan K; Gerber B
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():133-6. PubMed ID: 7961557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response of patients with treatment-refractory schizophrenia to clozapine within three serum level ranges.
    VanderZwaag C; McGee M; McEvoy JP; Freudenreich O; Wilson WH; Cooper TB
    Am J Psychiatry; 1996 Dec; 153(12):1579-84. PubMed ID: 8942454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine, cognition, and schizophrenia.
    Launer M
    Br J Psychiatry; 1993 Apr; 162():567-8. PubMed ID: 8481757
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical efficacy of clozapine in the treatment of schizophrenia.
    Meltzer HY; Alphs LD; Bastani B; Ramirez LF; Kwon K
    Pharmacopsychiatry; 1991 Mar; 24(2):44-5. PubMed ID: 1852789
    [No Abstract]   [Full Text] [Related]  

  • 36. Weight gain among schizophrenic patients treated with clozapine.
    Lamberti JS; Bellnier T; Schwarzkopf SB
    Am J Psychiatry; 1992 May; 149(5):689-90. PubMed ID: 1349460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clozapine for first-episode schizophrenia.
    Kolivakis TT; Margolese HC; Beauclair L; Chouinard G
    Am J Psychiatry; 2002 Feb; 159(2):317. PubMed ID: 11823283
    [No Abstract]   [Full Text] [Related]  

  • 38. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
    Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
    Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alprazolam augmentation of antipsychotic pharmacotherapy?
    Thienhaus OJ; Somoza E; Nobilski M
    Arch Gen Psychiatry; 1989 Nov; 46(11):1052-3. PubMed ID: 2818141
    [No Abstract]   [Full Text] [Related]  

  • 40. Does clozapine affect smoking rates?
    Chatterton R; Sanderson L; Van Leent S; Plant K
    Aust N Z J Psychiatry; 1998 Dec; 32(6):890-1. PubMed ID: 10084360
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.